ARTICLE | Clinical News
AclarusDx: Completed enrollment
July 23, 2012 7:00 AM UTC
Exonhit completed enrollment of 600 patients complaining of cognitive disorders or memory impairment in the French DIALOG trial evaluating AclarusDx. The product has CE Mark approval and is available ...